Grants for Small business in EU

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Outcome: Proposals are expected to contribute to the following outcomes: Steer a European agenda to catalyse the development of a full software defined and hardware-enabled vehicle AD stack “built in Europe”, from onboard-compute architecture up to software in-vehicle up to the cloud. Establish structured intersectoral linkages between software, AI/data, hardware and deployment actors, ensuring that architectural decisions in the European AD stack are aligned across computing platforms, AI models, validation frameworks and real-world deployment environments. Promote a European R&I roadmap establishing pathways for the accelerated development of a European AI-powered AD stack, notably in close liaison with the relevant ECAVA Working Groups and relevant OSS initiatives. Ensure the engagement of key stakeholders across the Automotive value chain (including relevant OSS initiatives) toward an open-source software autonomous driving stack, including required industrial partners (such as OEMs, suppliers, tool-providers), and innovative R&I stakeholders (RTOs, universities, start-ups. If useful, already existing OSS AD stack initiatives together with the reference stacks (as…

Expected Outcome: Projects should contribute to all of the following expected outcomes: Deepened knowledge of specific factors favouring the growth of creative startups [1] , in particular those with potential for disruptive innovation [2] and/or cross-sectorial innovation impacts, is made available and promoted to policymakers, investors, funding- and enterprise support bodies. Effective methods to favour the growth of creative startups, in particular those with potential for disruptive innovation and/or cross-sectorial innovation impacts, are developed, tested and put in practice by industry, investors, funding- and enterprise support bodies, and relevant decision makers. Examples of creative startups scaling up and/or engaging in disruptive innovation are made available, with a view to increase the visibility and recognition of the innovative power of Europe’s creative startups. In addition, proposals should contribute to at least one of the following expected outcomes, depending on the option chosen (a or b below): The effectiveness of the methods developed is demonstrated by at least one creative startup supported via the action becoming a scaleup [3] in a Member State or an…

Expected Outcome: Project results are expected to contribute to the following outcomes: Increased commercialisation of academic research results, by facilitating access for industry, startups and scaleups to the intellectual assets of academic research; Strengthened collaboration between industry and academia, reflected in an increased number of technology transfer deals and joint R&D projects resulting in market-ready innovations; Introduced more startup friendly intellectual asset transfer/licensing policies in universities/research and higher education institutions/RTOs; Increased number of spinoffs by enabling researchers to overcome the barriers to commercialising their intellectual assets; Reduced transaction costs related to Intellectual Property Rights (IPR) negotiations by establishing more standardised asset transfer policies across universities/research and higher education institutions/RTOs; Optimised transfer/licensing processes by universities/research and higher education institutions/RTOs based on grouping intellectual assets in portfolios that can be commercialised in package deals that are more attractive for industry and investors. Scope: Academic knowledge…

Expected Outcome: This action will support and accelerate the development and adoption of European and international standards for quantum technologies, enhancing interoperability quality/reliability assurance, and trust in quantum systems. It will strengthen Europe's leadership in the global quantum standardisation landscape and ensure that European industrial and research priorities are well represented and integrated into emerging standards. Expected outcomes include: Delivery of concrete, EU-relevant pre-normative standards and technical specifications across quantum computing, communication, and sensing. Substantial contribution of European stakeholders, notably SMEs and start-ups in international standardisation bodies (e.g., ISO/IEC, ITU-T, ETSI), with alignment to EU industrial strategies. Promotion of cross-sectoral interoperability through standardised interfaces, control protocols, reliability in operating conditions and benchmarking methodologies, reducing market fragmentation and technical barriers. Creation of practical support tools such as user guidelines, training modules, and best practices to accelerate the uptake and implementation of quantum…

Expected Outcome: Project results are expected to contribute to some or all of the following expected outcomes: A community of EU civil security practitioners with common user/functional needs for innovative technology solutions is identified, supported by an industrial base, in particular SMEs and Startups, to access the public procurement market and scale up their business; Procurers facilitated the commercialisation of the innovative solutions developed by their successful suppliers by providing them with first customer references for the validation and first pilot deployment; Tested and validated capacity of EU technology and industrial base to develop and produce technology prototypes that meet the diverse needs of the EU user community, regardless of their gender, age and ability; Improved delineation of the EU market (including demand and supply) for innovative civil security systems that can articulate alternative options for uptake in function of different industrialisation needs, commercialisation needs, acquisition needs, deployment needs and additional funding needs (beyond R&I funding). Scope: As past experience shows that pre-commercial procurement opens up the…

Expected Outcome: Objectives and profile of the ERC Advanced Grant Principal Investigator The objective of the Advanced Grant is to support excellent Principal Investigators that are established research leaders. An ERC Advanced Grant Principal Investigator is expected to be an active researcher with a track record of significant research achievements. Size of ERC Advanced Grants Advanced Grants may be awarded up to a maximum of EUR 2 500 000 for a period of 5 years . The maximum amount of the grants is reduced pro rata temporis for projects of a shorter duration. Additional funding up to EUR 1 000 000 * can be requested to cover further eligible costs (e.g. start-up costs, major equipment, access to large facilities, major experimental and field work costs) when these are necessary to carry out the proposed work. The requests for additional funding must be duly justified in the proposal. Additional funding is not subject to pro rata temporis reduction for projects of shorter duration. * Except for Principal Investigators in Starting, Consolidator, or Advanced Grant re-locating to the EU or an Associated Country from elsewhere to take up their ERC grant. In this case, the maximum…

Expected Impact: FOR ALL THREE THEMATIC PRIORITIES: Expected impact at the closure of the project (non-exhaustive list): Creation of new value chains in less developed regions and transition regions; Application and deployment of innovative technologies and solutions (new to the region) in less developed and transition regions (innovation diffusion); Exploitation of project results; Innovative technologies tested and adopted by the market; Innovative solutions deployed improving businesses confidence, competences and means to digitalise and grow; Contribution to digitisation and health systems transformation, through various types of innovation and the supply of IT services; Uptake of technologically/economically reliable and viable solutions on the market; Deployment of new technologies fostering the growth of Europe’s manufacturing sector; Innovative technologies adopted by SMEs; Identification of possible sources of funding/funding mix, to cover the residual investment needs (public-private partnerships for the deployment of innovation, the collaboration with venture capitals, EIB group loans etc); Strengthening innovation diffusion channels; Reinforcing the capacity of regions…

Expected Impact: FOR ALL THREE THEMATIC PRIORITIES: Expected impact at the closure of the project (non-exhaustive list): Innovative technologies tested and adopted by the market; Innovative solutions deployed improving businesses confidence, competences and means to digitalise and grow; Contribution to digitisation and health systems transformation, through various types of innovation and the supply of IT services; Uptake of technologically/economically reliable and viable solutions on the market; Deployment of new technologies fostering the growth of Europe’s manufacturing sector; Innovative technologies adopted by SMEs; Identification of possible sources of funding/funding mix, to cover the residual investment needs (public-private partnerships for the deployment of innovation, the collaboration with venture capitals, EIB group loans etc); Strengthening innovation diffusion channels; Reinforcing the capacity of regions to co-invest together, joining forces on common S3 investment priorities (interregional investments). Long-term impact (non-exhaustive list): Increased companies’ productivity and efficiency; Improved user-friendly, accessible and interoperable public…

Expected Outcome: Project results are expected to contribute to the following outcomes: For supported doctoral candidates New research and transferable skills and competences, leading to improved employability and career prospects within and outside academia; New knowledge allowing the conversion of ideas into products and services, where relevant; Enhanced networking and communication capacities with scientific peers, as well as with the general public that will increase and broaden the research and innovation impact. For participating organisations Improved quality, relevance and sustainability of doctoral training programmes and supervision arrangements; Enhanced cooperation and transfer of knowledge between sectors and disciplines; Increased integration of training and research activities between participating organisations; Boosted R&I capacity; Increased internationalisation and attractiveness; Regular feedback of research results into teaching and education at participating organisations. Scope: MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other…